Quantitative & Derivatives Strategy
Flows & Liquidity : Updated equity demand and supply for H2
July 10, 2024
Flows & Liquidity : Updated equity demand and supply for H2
Flows & Liquidity : Updated equity demand and supply for H2
This document is being provided for the exclusive use of blake@sandboxfp.com.
10 July 2024

This material is neither intended to be distributed to Mainland China investors nor to provide securities investment consultancy services within the territory of Mainland China. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan.

Flows & Liquidity

Updated equity demand and supply for H2

J.P. Morgan does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.


  • The increase in US equity futures positions to very elevated levels, with the net longs of Asset Managers and Leveraged funds as a % of open interest recently having reached their highest level in a decade, along with an elevated positioning of momentum traders, leaves equities vulnerable.
  • Our global equity demand-supply analysis suggests this increased long positions, along with a more negative equity supply backdrop, has supported equities in 1H24, but also represents a significant headwind for 2H24 assuming some mean reversion in positioning by institutional investors.
  • Our implied equity allocation of non-bank investors globally has risen to its previous October 2007 peak at the same time as the implied cash allocation breached its previous historical low of August 2000.
  • Our net flow estimate into digital assets YTD decreases to $8bn.

  • With the first half of the year behind us, and following the update to our global bond supply-demand balance last week, we revisit our analysis for equities.
  • Starting with supply, we noted earlier this year (F&L, Apr 3rd) that the global equity supply picture looked to have turned more negative in the first three months of the year amid a continued softness in IPO markets despite the ongoing strength in equity markets. Indeed, we noted that the elevated macro, geopolitical and policy uncertainty continue to hold back IPOs and this looked unlikely to change any time soon. One simple way to gauge net equity supply is to look at the change in the free float of the global equity universe as captured by tradable indices such as the MSCI AC World index. Adjusted for price and FX changes, this change in the free float should capture the increase or decrease in the quantity of shares available to markets in each period.

  • This proxy is shown in Figure 1 below, which suggests that global equity supply has continued to shift in a more negative direction this year. The current level of around -$180bn is the most negative level in our sample since 1999, and while negative net supply in the US has been a common occurrence over the past decade or so, non-US supply looks to have been negative for the first time since 2002. This negative supply has undoubtedly provided background support for equity markets from a supply perspective, and it looks likely to continue. On an annualized basis, this would imply net supply of -$360bn after net supply of -40bn in 2023, or a decline in supply of $320bn in 2024 vs. 2023.

Figure 1: Net equity supply globally

$bn per year based on the share count/divisor change of the MSCI AC World, adjusted for price and FX changes. 2024 YTD is up to Jul 9th.

Source: Bloomberg Finance L.P., LSEG, J.P. Morgan.

  • Turning to equity demand from institutional investors, in our equity demand-supply analysis from end-2023 we had argued that while the severe de-risking by institutional investors in 2022 had created ample space for them to propagate equity markets in 2023 simply through mean reversion, the increase in equity allocations during 2023 had effectively exhausted this reversion to mean. Since the turn of the year, we have been noting a continued increase in equity allocations. The equity positions of institutional investors are based on a combination of their exposure in cash and other derivative markets. Therefore, looking at our positioning metrics based on equity futures provides one way of gauging the change in positioning by institutional investors. An alternative way of estimating the change in equity demand by institutional investors is to look at their equity betas.
  • The equity betas of CTAs, Equity Long/Short hedge funds and Balanced Mutual funds are shown in Figure 2 to Figure 5. Starting with Equity Long/Short hedge funds, the biggest equity hedge fund sector with an AUM of $1.2tr, we proxy the equity beta of Equity L/S by looking at futures positions of asset managers and leveraged funds ( Figure 2) as Equity L/S uses futures as an overlay to achieve their desired beta. These futures positions of asset managers and leveraged funds are in turn proxied by the z-score of net CFTC positions as a % of open interest shown in Figure 2 and Chart A13 in the Appendix. A neutral z-score of zero is assumed to correspond to a historical average equity beta of 0.5 for Equity L/S hedge funds. We also assume that a very extreme 3 stdevs move in the z-score of CFTC futures positions corresponds to a very extreme 0.5 change in the equity beta. Using these assumptions, last year had seen a rise in the equity beta from 0.2 in late 2022 to around 0.6 in late 2023. A simple reversion to mean of 0.5 would imply net sales of equity around $180bn for this year, or a deterioration in net demand of around $1tr in 2024 vs. 2023 given the strength of demand last year. That said, as Figure 2 shows, the net longs of asset managers and leveraged funds as a % of open interest recently rose to their highest levels in a decade, suggesting increased equity positions that have supported equities in 1H24 but also imply a larger decline into year-end assuming simple mean reversion.

Figure 2: Positions in US equity futures by Asset managers and Leveraged funds

CFTC positions in US equity futures by Leveraged funds and Asset managers (as a % of open interest). It is an aggregate of the S&P500, Dow Jones, NASDAQ and their Mini futures contracts.

Source: CFTC, Bloomberg Finance L.P., J.P. Morgan.

  • What about momentum-based investors such as CTAs? Figure 3 shows the average z-score of the short and long lookback period momentum signals for the S&P, Nikkei, Eurostoxx 50, FTSE 100 and MSCI EM indices. This z-score rose from a relatively low level of close to 0.2 in end-2022 to 0.7 by late 2023. Assuming some reversion to its average in recent years of 0.5, this implies a deterioration in demand in 2024 relative to 2023 of around $140bn. But similar to the picture for Equity L/S above, the z-score has risen YTD to around 1.2 currently, which in turn implies that the equity flow of momentum-based investors has been supportive for equities in 1H24 and that this represents a greater headwind for 2H24 assuming mean reversion.

Figure 3: Weighted average of the z scores of equity index momentum signals

z-score of the momentum signals in our Trend Following Strategy framework shown in Tables A3 and A4 in the Appendix. The line shows the average z-score of the short and long lookback period momentum signals for the S&P 500, Nikkei, EuroStoxx50, FTSE100 and MSCI EM indices. We attach 50% weight on the S&P500 momentum signals and 50% weight on the momentum signals of the remaining four indices combined.

Source: CFTC, Bloomberg Finance L.P., J.P. Morgan.

  • What about the $150bn universe of risk parity funds? Our calculations suggest that the partial beta of risk parity fund returns to equity returns had effectively doubled from 0.16 in late 2022 to 0.32 in late 2023, which implied an improvement in equity demand of around $80bn in 2023 vs. 2022. Assuming mean reversion to its longer-term average of around 0.25, this would imply a shift from net buying of around $50bn in 2023 to net selling of just under £30bn, or a deterioration in equity demand of just under $80bn.

Figure 4: Equity beta of Risk Parity funds

Rolling 21-day equity beta based on a bivariate regression of the daily returns of our Risk Parity fund return index to the daily returns of the S&P 500 and Bloomberg US Agg indices.

Source: Bloomberg Finance L.P., J.P. Morgan.

  • We do a similar calculation for the much larger $7tr universe of Hybrid Mutual funds including Balanced Mutual funds. As we noted previously, 2023 saw an improvement in demand vs. 2022 of around $790bn as the beta rose from 0.54 in late 2022 to 0.61 in late 2023. For 2024, we still project mean reversion to its long-term average of around 0.6, which implies a net deterioration in demand in 2024 vs. 2023 of around $460bn.
  • What about pension funds and insurance companies? G4 insurance companies and pension funds, including both defined benefit and defined contribution plans, have typically been steady sellers of equities due to their structural shift away from equities towards fixed income. 2023 saw net sales reaching nearly $470bn, a deterioration in equity demand of around $125bn in 2023 vs. 2022. Given the strength in equity prices and the improvement in the funded status of defined benefit pension funds, we projected unchanged bond demand in 2024 vs. 2023 as the incentive to lock in gains remains and as it has taken somewhat longer for rebalancing flows to materialise than we had expected, and we similarly project unchanged net selling of equities in 2024 vs. 2023.
  • Central banks and SWFs saw some moderation in equity purchases in 2023 vs. 2022. Based on some moderation in current account balances of oil producing countries in 2024 vs. 2023, and our commodity strategists’ forecast for Brent prices averaging $84/bbl in 2024 vs. an average of $82/bbl in 2023, we estimate a modest $25bn deterioration of demand in 2024 vs. 2023.
  • What about retail investor demand? Last year had seen a return from close to zero net equity fund flows to inflows of around $230bn (Chart A1 in the Appendix), or an improvement of around $225bn, as the 4Q23 flows once quarterly reporting funds are included showed a sharp increase after modest inflows in for the first three quarters of the year. Thus far in 2024, equity funds including ETFs and mutual funds have seen net inflows of around $270bn with 1Q24 seeing particularly strong inflows, and similar to our Bond supply-demand update last week we assume 2H24 flows continue at the 2Q24 pace. This $440bn net inflow would represent a net improvement in bond demand of around $210bn, with inflows somewhat front-loaded in 1Q.
  • Where does this leave us for this year’s overall equity demand-supply balance? Assuming mean reversion in equity betas of institutional investors, as well as continued flows into equity ETFs and mutual funds from retail investors and the projected negative net supply, we come up with an equity demand/supply deterioration of around $1.2tr ( Figure 5). Taken at face value, this negative demand-supply balance stands at odds with the rally in equities YTD. However, this assumes mean reversion in the equity betas of institutional investors, while as we note above the equity betas have if anything increased YTD for CTAs and Equity L/S investors in particular. Given these elevated betas, as well as the rather high equity allocation and low cash allocation of global non-bank investors we highlight below, this suggests a material headwind for equities in 2H24.

Figure 5: Annual Change in Global Equity Demand/Supply Balance

Change in flows per year in $bn.

Year 2022 vs. 2021 2023 vs. 2022 2024 vs 2023
Demand
Retail investors -1062 223 209
CTAs 32 184 -140
Equity L/S -1474 2054 -1019
Risk Parity
Funds
0 79 -80
Balanced MF -305 789 -456
Pension &
Insurance Funds
258 -125 0
SWF/
Central banks
355 -309 -25
Total
Demand
-2196 2895 -1511
Supply -684 -47 -322
Demand -
Supply
-1513 2942 -1189

Source: J.P. Morgan.

Our implied equity allocation of non-bank investors globally has risen to its previous October 2007 peak at the same time as the implied cash allocation breached its previous historical low of August 2000

  • The relentless rally in US equities has expanded the stock of equities by so much, that our measure of the cash allocation by non-bank investors globally (which is proxied by the stock of M2 money supply divided by the stock of equities and bonds held outside banks), made a new historical low (at least since our data begin in 1999 as shown in Figure 6). In particular, the current cash allocation of 31.9% is lower than its previous historical low seen in August 2000 at 32.4%.

Figure 6: Implied cash allocation by non-bank investors globally

Global cash held by non-bank investors as % total holdings of equities/bonds/M2 bynon-bank investors. Dotted lines are averages.

Source: Bloomberg Finance L.P., J.P. Morgan.

  • The mirror image of the record low cash allocation has been an increase in the implied equity allocation which at 49% currently is almost equal to the previous peak of 49.6% seen in October 2007 ( Figure 7).
  • Given that global non-bank investors cash allocations are at historical low at the same as cash yields are at multi year highs, and given equity allocations are as high as they were at the peak of the 2007 cycle, we believe there is no much of a liquidity buffer to propagate financial assets from here or to absorb negative shocks, thus posing vulnerability to equity markets going forward.

Figure 7: Implied equity allocation by non-bank investors globally

Global equities as % total holdings of equities/bonds/M2 by non-bank investors.Dotted lines are averages.

Source: Bloomberg Finance L.P., J.P. Morgan.

Our net flow estimate into digital assets YTD decreases to $8bn

  • We had previously estimated a net flow into digital assets of $12bn by June 12th. This estimate was based on

1. the net inflow into crypto funds is $14.6bn by 12th June.

2. plus the flow impulse implied by CME futures of $5.1bn.

3. plus the fundraising by crypto venture capital funds of $4.9bn

4. minus a $13bn adjustment for the rotation away from digital wallets on exchanges to the new spot bitcoin ETFs. This is due to the cost effectiveness, deeper liquidity, regulatory protection and convenience of the ETF wrapper that has become market participant's preferred choice of instrument for bitcoin exposure for both existing and new crypto investors. This rotation away from digital wallets on exchanges was proxied by the decline in bitcoin reserves across exchanges which by June 12th was estimated by CryptoQuant at 0.22mn bitcoins or $13bn cumulatively since the ETF launch on January 10th.

  • Updating these estimates to date results to a lower net flow of $8bn comprised of

 1. the net inflow into crypto funds is $14bn by 9th July.

2. plus a flow impulse implied by CME futures of $5bn again to July 9th

3. plus the YTD fundraising by crypto venture capital funds of $5.7bn

4. minus a $17bn adjustment for the rotation away from digital wallets on exchanges to the new spot bitcoin ETFs. Again this is proxied by the decline in bitcoin reserves across exchanges which by July 9th was estimated by CryptoQuant at 0.29mn bitcoins or $17bn.

  • In other words our net flow estimate into digital assets YTD is decreased from $12bn to $8bn in only a month ( Figure 8). We were skeptical that the $12bn previously estimated to June 12th would continue into the remainder of the year given how high bitcoin prices were relative to bitcoin production cost or relative to gold. We have however surprised by how quickly this net flow has declined.
  • That said, the reduction in the estimated net flow is largely driven by the decline in bitcoin reserves across exchanges over the past month which in turn is likely to reflect bitcoin liquidations by Gemini creditors, or Mt. Gox creditors or the German government (in recent weeks the German government has been offloading bitcoins that were previously seized in criminal activities).
  • We believe that these liquidations will subside after July and we thus continue to look for a crypto market rebound from August onwards.

Figure 8: Total net flow into digital assets by year

$bn per year including crypto fund flows, the flow impulse implied by CME futures and crypto VC fundraising

Source: Bloomberg Finance L.P., Messari,, Defilama, J.P. Morgan.

Appendix

ETF Flow Monitor (as of 10th July)

Short Interest Monitor

Chart A11a: Cross Asset Volatility Monitor 3m ATM Implied Volatility (1y history) as of 1st July-2024

This table shows the richness/cheapness of current three-month implied volatility levels (red dot) against their one-year historical range (thin blue bar) and the ratio to current realised volatility. Assets with implied volatility outside their 25th/75th percentile range (thick blue bar) are highlighted. The implied-to-realised volatility ratio uses 3-month implied volatilities and 1-month (around 21 trading days) realised volatilities for each asset.

Spec position monitor

Mutual fund and hedge fund betas

CTAs – Trend following investors’ momentum indicators

Corporate Activity

Pension fund and insurance company flows

Credit Creation

Bitcoin monitor

Japanese flows and positions

Commodity flows and positions

Corporate FX hedging proxies

Non-Bank investors’ implied allocations

Analyst Certification: The Research Analyst(s) denoted by an “AC” on the cover of this report certifies (or, where multiple Research Analysts are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the Research Analyst(s) in this report. For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFIA requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion, without undue influence or intervention.

All authors named within this report are Research Analysts who produce independent research unless otherwise specified. In Europe, Sector Specialists (Sales and Trading) may be shown on this report as contacts but are not authors of the report or part of the Research Department.

Important Disclosures

An analyst listed on the front cover has personal holdings in digital or crypto assets.

Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan–covered companies, and certain non-covered companies, by visiting https://www.jpmm.com/research/disclosures, calling 1-800-477-0406, or e-mailing research.disclosure.inquiries@jpmorgan.com with your request.

Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe: J.P. Morgan uses the following rating system: Overweight (over the duration of the price target indicated in this report, we expect this stock will outperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); Neutral (over the duration of the price target indicated in this report, we expect this stock will perform in line with the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe); and Underweight (over the duration of the price target indicated in this report, we expect this stock will underperform the average total return of the stocks in the Research Analyst’s, or the Research Analyst’s team’s, coverage universe. NR is Not Rated. In this case, J.P. Morgan has removed the rating and, if applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a recommendation or a rating. In our Asia (ex-Australia and ex-India) and U.K. small- and mid-cap Equity Research, each stock’s expected total return is compared to the expected total return of a benchmark country market index, not to those Research Analysts’ coverage universe. If it does not appear in the Important Disclosures section of this report, the certifying Research Analyst’s coverage universe can be found on J.P. Morgan’s Research website, https://www.jpmorganmarkets.com.

J.P. Morgan Equity Research Ratings Distribution, as of July 06, 2024

Overweight(buy) Neutral(hold) Underweight(sell)
J.P. Morgan Global Equity Research Coverage* 49% 38% 13%
    IB clients** 49% 46% 34%
JPMS Equity Research Coverage* 48% 41% 11%
    IB clients** 69% 66% 50%

*Please note that the percentages may not add to 100% because of rounding.**Percentage of subject companies within each of the "buy," "hold" and "sell" categories for which J.P. Morgan has provided investment banking services within the previous 12 months. For purposes of FINRA ratings distribution rules only, our Overweight rating falls into a buy rating category; our Neutral rating falls into a hold rating category; and our Underweight rating falls into a sell rating category. Please note that stocks with an NR designation are not included in the table above. This information is current as of the end of the most recent calendar quarter.

Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst or your J.P. Morgan representative, or email research.disclosure.inquiries@jpmorgan.com. For material information about the proprietary models used, please see the Summary of Financials in company-specific research reports and the Company Tearsheets, which are available to download on the company pages of our client website, http://www.jpmorganmarkets.com. This report also sets out within it the material underlying assumptions used.

A history of J.P. Morgan investment recommendations disseminated during the preceding 12 months can be accessed on the Research & Commentary page of http://www.jpmorganmarkets.com where you can also search by analyst name, sector or financial instrument.

Analysts' Compensation: The research analysts responsible for the preparation of this report receive compensation based upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues.

Registration of non-US Analysts: Unless otherwise noted, the non-US analysts listed on the front of this report are employees of non-US affiliates of J.P. Morgan Securities LLC, may not be registered as research analysts under FINRA rules, may not be associated persons of J.P. Morgan Securities LLC, and may not be subject to FINRA Rule 2241 or 2242 restrictions on communications with covered companies, public appearances, and trading securities held by a research analyst account.

Other Disclosures

J.P. Morgan is a marketing name for investment banking businesses of JPMorgan Chase & Co. and its subsidiaries and affiliates worldwide.

UK MIFID FICC research unbundling exemption: UK clients should refer to UK MIFID Research Unbundling exemption for details of J.P. Morgan’s implementation of the FICC research exemption and guidance on relevant FICC research categorisation.

All research material made available to clients are simultaneously available on our client website, J.P. Morgan Markets, unless specifically permitted by relevant laws. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research material available on a particular stock, please contact your sales representative.

Any long form nomenclature for references to China; Hong Kong; Taiwan; and Macau within this research material are Mainland China; Hong Kong SAR (China); Taiwan (China); and Macau SAR (China).

J.P. Morgan Research may, from time to time, write on issuers or securities targeted by economic or financial sanctions imposed or administered by the governmental authorities of the U.S., EU, UK or other relevant jurisdictions (Sanctioned Securities). Nothing in this report is intended to be read or construed as encouraging, facilitating, promoting or otherwise approving investment or dealing in such Sanctioned Securities. Clients should be aware of their own legal and compliance obligations when making investment decisions.

Any digital or crypto assets discussed in this research report are subject to a rapidly changing regulatory landscape. For relevant regulatory advisories on crypto assets, including bitcoin and ether, please see https://www.jpmorgan.com/disclosures/cryptoasset-disclosure.

The author(s) of this research report may not be licensed to carry on regulated activities in your jurisdiction and, if not licensed, do not hold themselves out as being able to do so.

Exchange-Traded Funds (ETFs): J.P. Morgan Securities LLC (“JPMS”) acts as authorized participant for substantially all U.S.-listed ETFs. To the extent that any ETFs are mentioned in this report, JPMS may earn commissions and transaction-based compensation in connection with the distribution of those ETF shares and may earn fees for performing other trade-related services, such as securities lending to short sellers of the ETF shares. JPMS may also perform services for the ETFs themselves, including acting as a broker or dealer to the ETFs. In addition, affiliates of JPMS may perform services for the ETFs, including trust, custodial, administration, lending, index calculation and/or maintenance and other services.

Options and Futures related research: If the information contained herein regards options- or futures-related research, such information is available only to persons who have received the proper options or futures risk disclosure documents. Please contact your J.P. Morgan Representative or visit https://www.theocc.com/components/docs/riskstoc.pdf for a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options or http://www.finra.org/sites/default/files/Security_Futures_Risk_Disclosure_Statement_2018.pdf for a copy of the Security Futures Risk Disclosure Statement.

Changes to Interbank Offered Rates (IBORs) and other benchmark rates: Certain interest rate benchmarks are, or may in the future become, subject to ongoing international, national and other regulatory guidance, reform and proposals for reform. For more information, please consult: https://www.jpmorgan.com/global/disclosures/interbank_offered_rates

Private Bank Clients: Where you are receiving research as a client of the private banking businesses offered by JPMorgan Chase & Co. and its subsidiaries (“J.P. Morgan Private Bank”), research is provided to you by J.P. Morgan Private Bank and not by any other division of J.P. Morgan, including, but not limited to, the J.P. Morgan Corporate and Investment Bank and its Global Research division.

Legal entity responsible for the production and distribution of research: The legal entity identified below the name of the Reg AC Research Analyst who authored this material is the legal entity responsible for the production of this research. Where multiple Reg AC Research Analysts authored this material with different legal entities identified below their names, these legal entities are jointly responsible for the production of this research. Research Analysts from various J.P. Morgan affiliates may have contributed to the production of this material but may not be licensed to carry out regulated activities in your jurisdiction (and do not hold themselves out as being able to do so). Unless otherwise stated below, this material has been distributed by the legal entity responsible for production. If you have any queries, please contact the relevant Research Analyst in your jurisdiction or the entity in your jurisdiction that has distributed this research material.

Legal Entities Disclosures and Country-/Region-Specific Disclosures: Argentina: JPMorgan Chase Bank N.A Sucursal Buenos Aires is regulated by Banco Central de la República Argentina (“BCRA”- Central Bank of Argentina) and Comisión Nacional de Valores (“CNV”- Argentinian Securities Commission - ALYC y AN Integral N°51). Australia: J.P. Morgan Securities Australia Limited (“JPMSAL”) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by the Australian Securities and Investments Commission and is a Market Participant of ASX Limited, a Clearing and Settlement Participant of ASX Clear Pty Limited and a Clearing Participant of ASX Clear (Futures) Pty Limited. This material is issued and distributed in Australia by or on behalf of JPMSAL only to "wholesale clients" (as defined in section 761G of the Corporations Act 2001). A list of all financial products covered can be found by visiting https://www.jpmm.com/research/disclosures. J.P. Morgan seeks to cover companies of relevance to the domestic and international investor base across all Global Industry Classification Standard (GICS) sectors, as well as across a range of market capitalisation sizes. If applicable, in the course of conducting public side due diligence on the subject company(ies), the Research Analyst team may at times perform such diligence through corporate engagements such as site visits, discussions with company representatives, management presentations, etc. Research issued by JPMSAL has been prepared in accordance with J.P. Morgan Australia’s Research Independence Policy which can be found at the following link: J.P. Morgan Australia - Research Independence Policy. Brazil : Banco J.P. Morgan S.A. is regulated by the Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Ombudsman J.P. Morgan: 0800-7700847 / 0800-7700810 (For Hearing Impaired) / ouvidoria.jp.morgan@jpmorgan.com. Canada : J.P. Morgan Securities Canada Inc. is a registered investment dealer, regulated by the Canadian Investment Regulatory Organization and the Ontario Securities Commission and is the participating member on Canadian exchanges. This material is distributed in Canada by or on behalf of J.P.Morgan Securities Canada Inc. Chile: Inversiones J.P. Morgan Limitada is an unregulated entity incorporated in Chile. China: J.P. Morgan Securities (China) Company Limited has been approved by CSRC to conduct the securities investment consultancy business. Dubai International Financial Centre (DIFC) : JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial Services Authority (DFSA) and its registered address is Dubai International Financial Centre - The Gate, West Wing, Level 3 and 9 PO Box 506551, Dubai, UAE. This material has been distributed by JP Morgan Chase Bank, N.A., Dubai Branch to persons regarded as professional clients or market counterparties as defined under the DFSA rules. European Economic Area (EEA): Unless specified to the contrary, research is distributed in the EEA by J.P. Morgan SE (“JPM SE”), which is authorised as a credit institution by the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht, BaFin) and jointly supervised by the BaFin, the German Central Bank (Deutsche Bundesbank) and the European Central Bank (ECB). JPM SE is a company headquartered in Frankfurt with registered address at TaunusTurm, Taunustor 1, Frankfurt am Main, 60310, Germany. The material has been distributed in the EEA to persons regarded as professional investors (or equivalent) pursuant to Art. 4 para. 1 no. 10 and Annex II of MiFID II and its respective implementation in their home jurisdictions (“EEA professional investors”). This material must not be acted on or relied on by persons who are not EEA professional investors. Any investment or investment activity to which this material relates is only available to EEA relevant persons and will be engaged in only with EEA relevant persons. Hong Kong : J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong, and J.P. Morgan Broking (Hong Kong) Limited (CE number AAB027) is regulated by the Securities and Futures Commission in Hong Kong. JP Morgan Chase Bank, N.A., Hong Kong Branch (CE Number AAL996) is regulated by the Hong Kong Monetary Authority and the Securities and Futures Commission, is organized under the laws of the United States with limited liability. Where the distribution of this material is a regulated activity in Hong Kong, the material is distributed in Hong Kong by or through J.P. Morgan Securities (Asia Pacific) Limited and/or J.P. Morgan Broking (Hong Kong) Limited. India : J.P. Morgan India Private Limited (Corporate Identity Number - U67120MH1992FTC068724), having its registered office at J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz - East, Mumbai – 400098, is registered with the Securities and Exchange Board of India (SEBI) as a ‘Research Analyst’ having registration number INH000001873. J.P. Morgan India Private Limited is also registered with SEBI as a member of the National Stock Exchange of India Limited and the Bombay Stock Exchange Limited (SEBI Registration Number – INZ000239730) and as a Merchant Banker (SEBI Registration Number - MB/INM000002970). Telephone: 91-22-6157 3000, Facsimile: 91-22-6157 3990 and Website: http://www.jpmipl.com. JPMorgan Chase Bank, N.A. - Mumbai Branch is licensed by the Reserve Bank of India (RBI) (Licence No. 53/ Licence No. BY.4/94; SEBI - IN/CUS/014/ CDSL : IN-DP-CDSL-444-2008/ IN-DP-NSDL-285-2008/ INBI00000984/ INE231311239) as a Scheduled Commercial Bank in India, which is its primary license allowing it to carry on Banking business in India and other activities, which a Bank branch in India are permitted to undertake. For non-local research material, this material is not distributed in India by J.P. Morgan India Private Limited. Compliance Officer: Spurthi Gadamsetty; spurthi.gadamsetty@jpmchase.com; +912261573225. Grievance Officer: Ramprasadh K, jpmipl.research.feedback@jpmorgan.com; +912261573000.

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Indonesia : PT J.P. Morgan Sekuritas Indonesia is a member of the Indonesia Stock Exchange and is registered and supervised by the Otoritas Jasa Keuangan (OJK). Korea : J.P. Morgan Securities (Far East) Limited, Seoul Branch, is a member of the Korea Exchange (KRX). JPMorgan Chase Bank, N.A., Seoul Branch, is licensed as a branch office of foreign bank (JPMorgan Chase Bank, N.A.) in Korea. Both entities are regulated by the Financial Services Commission (FSC) and the Financial Supervisory Service (FSS). For non-macro research material, the material is distributed in Korea by or through J.P. Morgan Securities (Far East) Limited, Seoul Branch. Japan : JPMorgan Securities Japan Co., Ltd. and JPMorgan Chase Bank, N.A., Tokyo Branch are regulated by the Financial Services Agency in Japan. Malaysia : This material is issued and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X), which is a Participating Organization of Bursa Malaysia Berhad and holds a Capital Markets Services License issued by the Securities Commission in Malaysia. Mexico : J.P. Morgan Casa de Bolsa, S.A. de C.V. and J.P. Morgan Grupo Financiero are members of the Mexican Stock Exchange and are authorized to act as a broker dealer by the National Banking and Securities Exchange Commission. New Zealand : This material is issued and distributed by JPMSAL in New Zealand only to "wholesale clients" (as defined in the Financial Markets Conduct Act 2013). JPMSAL is registered as a Financial Service Provider under the Financial Service providers (Registration and Dispute Resolution) Act of 2008. Philippines : J.P. Morgan Securities Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Singapore : This material is issued and distributed in Singapore by or through J.P. Morgan Securities Singapore Private Limited (JPMSS) [MCI (P) 030/08/2023 and Co. Reg. No.: 199405335R], which is a member of the Singapore Exchange Securities Trading Limited, and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB Singapore), both of which are regulated by the Monetary Authority of Singapore. This material is issued and distributed in Singapore only to accredited investors, expert investors and institutional investors, as defined in Section 4A of the Securities and Futures Act, Cap. 289 (SFA). This material is not intended to be issued or distributed to any retail investors or any other investors that do not fall into the classes of “accredited investors,” “expert investors” or “institutional investors,” as defined under Section 4A of the SFA. Recipients of this material in Singapore are to contact JPMSS or JPMCB Singapore in respect of any matters arising from, or in connection with, the material. South Africa : J.P. Morgan Equities South Africa Proprietary Limited and JPMorgan Chase Bank, N.A., Johannesburg Branch are members of the Johannesburg Securities Exchange and are regulated by the Financial Services Conduct Authority (FSCA). Taiwan : J.P. Morgan Securities (Taiwan) Limited is a participant of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau. Material relating to equity securities is issued and distributed in Taiwan by J.P. Morgan Securities (Taiwan) Limited, subject to the license scope and the applicable laws and the regulations in Taiwan. According to Paragraph 2, Article 7-1 of Operational Regulations Governing Securities Firms Recommending Trades in Securities to Customers (as amended or supplemented) and/or other applicable laws or regulations, please note that the recipient of this material is not permitted to engage in any activities in connection with the material that may give rise to conflicts of interests, unless otherwise disclosed in the “Important Disclosures” in this material. Thailand : This material is issued and distributed in Thailand by JPMorgan Securities (Thailand) Ltd., which is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and Exchange Commission, and its registered address is 3rd Floor, 20 North Sathorn Road, Silom, Bangrak, Bangkok 10500. UK: Unless specified to the contrary, research is distributed in the UK by J.P. Morgan Securities plc (“JPMS plc”) which is a member of the London Stock Exchange and is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. JPMS plc is registered in England & Wales No. 2711006, Registered Office 25 Bank Street, London, E14 5JP. This material is directed in the UK only to: (a) persons having professional experience in matters relating to investments falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) (Order) 2005 (“the FPO”); (b) persons outlined in article 49 of the FPO (high net worth companies, unincorporated associations or partnerships, the trustees of high value trusts, etc.); or (c) any persons to whom this communication may otherwise lawfully be made; all such persons being referred to as "UK relevant persons". This material must not be acted on or relied on by persons who are not UK relevant persons. Any investment or investment activity to which this material relates is only available to UK relevant persons and will be engaged in only with UK relevant persons. Research issued by JPMS plc has been prepared in accordance with JPMS plc's policy for prevention and avoidance of conflicts of interest related to the production of Research which can be found at the following link: J.P. Morgan EMEA - Research Independence Policy. U.S .: J.P. Morgan Securities LLC (“JPMS”) is a member of the NYSE, FINRA, SIPC, and the NFA. JPMorgan Chase Bank, N.A. is a member of the FDIC. Material published by non-U.S. affiliates is distributed in the U.S. by JPMS who accepts responsibility for its content.

General: Additional information is available upon request. The information in this material has been obtained from sources believed to be reliable. While all reasonable care has been taken to ensure that the facts stated in this material are accurate and that the forecasts, opinions and expectations contained herein are fair and reasonable, JPMorgan Chase & Co. or its affiliates and/or subsidiaries (collectively J.P. Morgan) make no representations or warranties whatsoever to the completeness or accuracy of the material provided, except with respect to any disclosures relative to J.P. Morgan and the Research Analyst's involvement with the issuer that is the subject of the material. Accordingly, no reliance should be placed on the accuracy, fairness or completeness of the information contained in this material. There may be certain discrepancies with data and/or limited content in this material as a result of calculations, adjustments, translations to different languages, and/or local regulatory restrictions, as applicable. These discrepancies should not impact the overall investment analysis, views and/or recommendations of the subject company(ies) that may be discussed in the material. J.P. Morgan accepts no liability whatsoever for any loss arising from any use of this material or its contents, and neither J.P. Morgan nor any of its respective directors, officers or employees, shall be in any way responsible for the contents hereof, apart from the liabilities and responsibilities that may be imposed on them by the relevant regulatory authority in the jurisdiction in question, or the regulatory regime thereunder. Opinions, forecasts or projections contained in this material represent J.P. Morgan's current opinions or judgment as of the date of the material only and are therefore subject to change without notice. Periodic updates may be provided on companies/industries based on company-specific developments or announcements, market conditions or any other publicly available information. There can be no assurance that future results or events will be consistent with any such opinions, forecasts or projections, which represent only one possible outcome. Furthermore, such opinions, forecasts or projections are subject to certain risks, uncertainties and assumptions that have not been verified, and future actual results or events could differ materially. The value of, or income from, any investments referred to in this material may fluctuate and/or be affected by changes in exchange rates. All pricing is indicative as of the close of market for the securities discussed, unless otherwise stated. Past performance is not indicative of future results. Accordingly, investors may receive back less than originally invested. This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. This material may include views on structured securities, options, futures and other derivatives. These are complex instruments, may involve a high degree of risk and may be appropriate investments only for sophisticated investors who are capable of understanding and assuming the risks involved. The recipients of this material must make their own independent decisions regarding any securities or financial instruments mentioned herein and should seek advice from such independent financial, legal, tax or other adviser as they deem necessary. J.P. Morgan may trade as a principal on the basis of the Research Analysts’ views and research, and it may also engage in transactions for its own account or for its clients’ accounts in a manner inconsistent with the views taken in this material, and J.P. Morgan is under no obligation to ensure that such other communication is brought to the attention of any recipient of this material. Others within J.P. Morgan, including Strategists, Sales staff and other Research Analysts, may take views that are inconsistent with those taken in this material. Employees of J.P. Morgan not involved in the preparation of this material may have investments in the securities (or derivatives of such securities) mentioned in this material and may trade them in ways different from those discussed in this material. This material is not an advertisement for or marketing of any issuer, its products or services, or its securities in any jurisdiction.

Confidentiality and Security Notice : This transmission may contain information that is privileged, confidential, legally privileged, and/or exempt from disclosure under applicable law. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or use of the information contained herein (including any reliance thereon) is STRICTLY PROHIBITED. Although this transmission and any attachments are believed to be free of any virus or other defect that might affect any computer system into which it is received and opened, it is the responsibility of the recipient to ensure that it is virus free and no responsibility is accepted by JPMorgan Chase & Co., its subsidiaries and affiliates, as applicable, for any loss or damage arising in any way from its use. If you received this transmission in error, please immediately contact the sender and destroy the material in its entirety, whether in electronic or hard copy format. This message is subject to electronic monitoring: https://www.jpmorgan.com/disclosures/email

MSCI: Certain information herein (“Information”) is reproduced by permission of MSCI Inc., its affiliates and information providers (“MSCI”) ©2024. No reproduction or dissemination of the Information is permitted without an appropriate license. MSCI MAKES NO EXPRESS OR IMPLIED WARRANTIES (INCLUDING MERCHANTABILITY OR FITNESS) AS TO THE INFORMATION AND DISCLAIMS ALL LIABILITY TO THE EXTENT PERMITTED BY LAW. No Information constitutes investment advice, except for any applicable Information from MSCI ESG Research. Subject also to msci.com/disclaimer

Sustainalytics: Certain information, data, analyses and opinions contained herein are reproduced by permission of Sustainalytics and: (1) includes the proprietary information of Sustainalytics; (2) may not be copied or redistributed except as specifically authorized; (3) do not constitute investment advice nor an endorsement of any product or project; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Sustainalytics is not responsible for any trading decisions, damages or other losses related to it or its use. The use of the data is subject to conditions available at https://www.sustainalytics.com/legal-disclaimers. ©2024 Sustainalytics. All Rights Reserved.

"Other Disclosures" last revised July 06, 2024.

Copyright 2024 JPMorgan Chase & Co. All rights reserved. This material or any portion hereof may not be reprinted, sold or redistributed without the written consent of J.P. Morgan. It is strictly prohibited to use or share without prior written consent from J.P. Morgan any research material received from J.P. Morgan or an authorized third-party (“J.P. Morgan Data”) in any third-party artificial intelligence (“AI”) systems or models when such J.P. Morgan Data is accessible by a third-party. It is permissible to use J.P. Morgan Data for internal business purposes only in an AI system or model that protects the confidentiality of J.P. Morgan Data so as to prevent any and all access to or use of such J.P. Morgan Data by any third-party. #$J&098$#*P

Completed 10 Jul 2024 08:56 PM BSTDisseminated 10 Jul 2024 08:56 PM BST